TrialClinical cancer research : an official journal of the American Association for Cancer Research2011

A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer.

Heather L McArthur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.